China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results



GUANGZHOU, China, March 25 /Xinhua-PRNewswire/—China Medicine
Corporation (OTC Bulletin Board: CHME) ("China Medicine” or “the Company"),
a leading developer and distributor of prescription and over the counter
pharmaceuticals, traditional Chinese medicines (TCM), nutritional and
dietary supplements, medical devices, and medical formulations today
announced that it will conduct a conference call at 9:00 a.m. Eastern Time
on Thursday, March 27, 2008 to discuss the fourth quarter and fiscal year
2007 results.

Joining Mr. Shensan Yang, Chairman and Chief Executive Officer of China
Medicine, will be Ms. Huizhen Yu, Chief Financial Officer. The Company
plans to make an earnings announcement prior to the call.

To participate in the live conference call, please dial the following
number five to ten minutes prior to the scheduled conference call time:
888- 419-5570. International callers should dial 617-896-9871, Conference
Passcode: 25022850.

If you are unable to participate in the call at this time, a replay
will be available for fourteen days starting on Thursday, March 27 at 11:00
a.m. Eastern Time. To access the replay, dial 888-286-8010, international
callers dial 617-801-6888, Passcode: 92139283.

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which
discovers, develops, and distributes over 2,200 pharmaceutical products in
China including prescription and over the counter ("OTC") drugs,
traditional Chinese medicine ("TCM") products, herbs and dietary
supplements. The Company distributes the products to wholesale distributors
in 28 provinces, over 300 hospitals, 500 medicine companies, and 1,788 drug
stores throughout China. The Company actively develops a number of
proprietary products for many uses including oncology, high blood pressure
and the removal of toxins from food and animal feeds. For more information
visit the Company’s website at http://www.chinamedicinecorp.com .

About CCG Elite

CCG Elite is uniquely positioned to provide an outsourced, high-level
investor relations solution that combines in-depth understanding of Asia’s
corporate culture and economic scene and a direct pipeline into the leading
funds and broker-dealers in the U.S. CCG Elite is a global, full-service
investor relations agency with corporate headquarters in Los Angeles and
offices in New York City, Newport Beach, Calif., Dallas, Texas, Hong Kong
and Beijing. For further information, contact CCG Elite directly, or visit
the Company’s Web site at http://www.ccgelite.com .

Cautionary Statement

This press release contains forward-looking statements concerning the
Company’s business, products and financial results. The Company’s actual
results may differ materially from those anticipated in the forward-looking
statements depending on a number of risk factors including, but not limited
to, the following: general economic and business conditions, development,
shipment, market acceptance, additional competition from existing and new
competitors, changes in technology, and various other factors beyond the
Company’s control. All forward-looking statements are expressly qualified
in their entirety by this Cautionary Statement and the risk factors
detailed in the Company’s reports filed with the Securities and Exchange
Commission. China Medicine Corporation undertakes no duty to revise or
update any forward-looking statements to reflect events or circumstances
after the date of this release.

For more information, please contact:

Company Contact:
Ms. Huizhen Yu
Chief Financial Officer
China Medicine Corporation
Tel:  +86-20-8739-1718
Email:

Investor Relations Contact:
Mr. Crocker Coulson
President
CCG Elite Investor Relations
Tel:  +1-646-213-1915 (NY Office)
Email:

SOURCE China Medicine Corporation